Q3 2024 Holdings
Filed 2024-11-14 | 154 holdings | $1.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Evolus Inc(EOLS) | COM | 30052C107 | $78.5M | 4,847,399 | 5.6% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $74.2M | 2,254,797 | 5.3% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $53.0M | 7,229,500 | 3.8% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $51.0M | 2,242,925 | 3.6% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $50.2M | 1,287,107 | 3.6% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $50.0M | 4,321,547 | 3.6% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $44.6M | 1,330,879 | 3.2% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $34.4M | 1,105,600 | 2.5% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $34.3M | 300,000 | 2.4% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $32.1M | 270,000 | 2.3% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $26.8M | 450,000 | 1.9% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $26.0M | 700,000 | 1.9% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $25.3M | 3,568,058 | 1.8% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $24.6M | 2,407,800 | 1.8% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $23.2M | 2,730,000 | 1.7% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $23.1M | 1,500,000 | 1.6% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $22.0M | 300,000 | 1.6% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $21.2M | 1,900,000 | 1.5% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $20.2M | 700,000 | 1.4% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $18.4M | 450,000 | 1.3% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $18.2M | 766,940 | 1.3% |
| Nvidia Corporation(NVDA) | COM | 67066G104 | $17.9M | 147,732 | 1.3% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $17.3M | 150,000 | 1.2% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $16.9M | 2,750,000 | 1.2% |
| Avadel Pharmaceuticals PLC | COM SHS | G29687103 | $16.1M | 1,230,000 | 1.2% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $15.7M | 628,609 | 1.1% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $15.6M | 140,000 | 1.1% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $15.4M | 4,607,060 | 1.1% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $15.4M | 921,138 | 1.1% |
| Meta Platforms Inc(META) | CL A | 30303M102 | $14.8M | 25,855 | 1.1% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $13.9M | 750,000 | 1.0% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $13.8M | 1,100,000 | 1.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $13.2M | 1,200,000 | 0.9% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $13.0M | 2,500,000 | 0.9% |
| Cargo Therapeutics Inc(CRGX) | COM | 14179K101 | $12.9M | 700,749 | 0.9% |
| Teladoc Health Inc(TDOC) | COM | 87918A105 | $12.9M | 1,400,000 | 0.9% |
| Novavax Inc(NVAX) | COM NEW | 670002401 | $12.6M | 1,000,000 | 0.9% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $12.5M | 266,500 | 0.9% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $12.4M | 600,000 | 0.9% |
| Adicet BIO Inc(TORCEUR) | COM | 007002108 | $11.8M | 8,216,960 | 0.8% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $11.7M | 150,000 | 0.8% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $11.2M | 281,200 | 0.8% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $11.0M | 2,353,307 | 0.8% |
| Immunome Inc(IMNM) | COM | 45257U108 | $10.5M | 720,000 | 0.8% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $9.2M | 7,811,760 | 0.7% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $8.9M | 3,900,000 | 0.6% |
| Elanco Animal Health Inc(ELAN) | COM | 28414H103 | $8.8M | 600,000 | 0.6% |
| Hillevax Inc | COM | 43157M102 | $8.7M | 4,920,000 | 0.6% |
| Outlook Therapeutics Inc(OTLK) | COM | 69012T305 | $8.3M | 1,559,560 | 0.6% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $8.3M | 37,000 | 0.6% |